Financial results - ALEMI PHARMA SRL

Financial Summary - Alemi Pharma Srl
Unique identification code: 18908190
Registration number: J2006002402134
Nace: 4773
Sales - Ron
442.761
Net Profit - Ron
-5.782
Employees
4
Open Account
Company Alemi Pharma Srl with Fiscal Code 18908190 recorded a turnover of 2024 of 442.761, with a net profit of -5.782 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Alemi Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 584.516 298.074 393.535 314.019 285.639 358.170 378.661 428.713 401.189 442.761
Total Income - EUR 590.422 316.147 394.328 318.246 294.490 358.182 382.959 430.567 401.307 442.774
Total Expenses - EUR 559.325 357.633 388.125 328.655 288.417 313.780 351.141 404.921 394.168 435.265
Gross Profit/Loss - EUR 31.097 -41.487 6.204 -10.410 6.073 44.402 31.818 25.646 7.139 7.509
Net Profit/Loss - EUR 22.211 -41.487 1.243 -13.594 3.120 41.006 28.088 21.422 3.727 -5.782
Employees 6 5 5 6 5 5 5 5 5 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 11.0%, from 401.189 euro in the year 2023, to 442.761 euro in 2024. The Net Profit decreased by -3.706 euro, from 3.727 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Alemi Pharma Srl

Rating financiar

Financial Rating -
ALEMI PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Alemi Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Alemi Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Alemi Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Alemi Pharma Srl - CUI 18908190

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 35.581 18.015 15.195 20.950 6.654 5.506 32.565 26.368 16.984 9.109
Current Assets 269.128 104.454 100.209 72.232 51.279 80.084 88.364 96.565 85.257 81.991
Inventories 45.355 32.156 50.448 31.485 25.514 43.170 31.118 36.941 36.210 31.529
Receivables 223.370 70.292 58.255 47.677 25.475 32.235 24.956 50.774 33.902 30.845
Cash 403 2.006 -8.495 -6.930 290 4.679 32.290 8.849 15.145 19.617
Shareholders Funds 90.896 24.340 -22.643 -39.893 -36.000 5.689 28.330 21.665 5.110 -5.541
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 213.813 98.130 138.047 133.074 93.934 79.901 92.599 101.268 97.131 96.642
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 81.991 euro in 2024 which includes Inventories of 31.529 euro, Receivables of 30.845 euro and cash availability of 19.617 euro.
The company's Equity was valued at -5.541 euro, while total Liabilities amounted to 96.642 euro. Equity decreased by -10.623 euro, from 5.110 euro in 2023, to -5.541 in 2024.

Risk Reports Prices

Reviews - Alemi Pharma Srl

Comments - Alemi Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.